Ocrelizumab May Help Preserve Hand, Arm Function in PPMS

MONDAY, Nov. 26, 2018 -- For patients with primary progressive multiple sclerosis (PPMS), ocrelizumab reduces progression of upper-extremity (UE) impairment, according to an exploratory analysis published online Nov. 12 in the Multiple Sclerosis...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news